Determination of Pneumothorax Post Lung Biopsy

Role of Ultrasonography in the Diagnosis of Pneumothorax Following Transbronchial Biopsy in LungTransplant Patients.

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02840032

Enrollment

Registered

2016-07-21

Start date

2016-07-31

Completion date

2017-08-31

Last updated

2018-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumothorax

Brief summary

Bedside ultrasonography for detection of pneumothorax after transbronchial lung biopsies in lung transplant patients

Detailed description

The patients who undergo transbronchial forceps lung biopsies get a routine CXR after the biopsies are performed. The reason for CXR is to find out if pneumothorax occurred or not. CXR is required patient transportation and interpretation by the radiologist as well as time consuming. Instead, we are planning to perform bedside ultrasound to determine if pneumothorax occurred or not

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Any lung transplant patient who undergoes to bronchoscopic lung biopsy

Exclusion criteria

* Patients develop respiratory failure during the procedure

Design outcomes

Primary

Measure	Time frame
Determination of pneumothorax after transbronchial lung biopsy	2 hours

Countries

United States

Outcome results